Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Terveystalo

7.05 EUR-5.75 %7.10, 17.29
12,348 following

TTALO

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor views
Compare
-5.75 %
-11.10 %
-6.99 %
-17.35 %
-27.91 %
-29.92 %
-5.50 %
-36.03 %
-29.50 %

Terveystalo operates in the healthcare sector. The company offers services and solutions such as surveys and examinations, training and coaching, rehabilitation, and health and fitness mapping. Its customers include small and medium-sized corporate customers, as well as public sector players. The head office is located in Helsinki.

Read more
Market cap
895.61M EUR
Turnover
3.08M EUR
P/E (adj.) (26e)
10.64
EV/EBIT (adj.) (26e)
11.96
P/B (26e)
1.56
EV/S (26e)
1.27
Dividend yield-% (26e)
3.97 %
Coverage
Recommendation
Reduce
Target price
7.60 EUR
Updated
07.09.2026
Disclaimer
Roni Peuranheimo
Roni Peuranheimo

Analyst

Latest research

Latest analysis report

Released: 08.09.2026

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
Terveystalo is making acquisitions again. Inderes Terveystalo vahvistaa kykyään tukea hyvinvointialueita ostamalla Solo Healthin... Terveystalo vahvistaa kykyään tukea hyvinvointialueita ostamalla Solo HealthinTerveystalo Oyj, lehdistötiedote 4.9.2026 klo 16.00Terveystalo Healthcare...
9/4/2026, 1:02 PM
by KuHa
25
When the shareholder list updated at the turn of the month, the share sales by Rettig—who was still the largest shareholder a month ago—caught my eye. Following these sales, Varma is now the largest shareholder. Once the Silmäasema transaction goes through, the situation will naturally...
10/1/2026, 9:26 AM
by Roni Peuranheimo
19
Terveystalo will be providing a brief strategy update in connection with its Q3 results on October 21. The Capital Markets Day, originally planned for December, is being postponed to spring 2027. Quite logical in my opinion, as Silmäasema naturally plays a significant role in the...
8 hours ago
by Roni Peuranheimo
11
Terveystalo’s CFO jumps to Tieto: Inderes Muutos Terveystalon johtoryhmässä: Juuso Pajunen uuteen tehtävään yhtiön... Muutos Terveystalon johtoryhmässä: Juuso Pajunen uuteen tehtävään yhtiön ulkopuolelleTerveystalo Oyj pörssitiedote 16.9.2026 klo 9.00Terveystalon johtoryhmän jäsen...
9/16/2026, 6:05 AM
by Kari Runq
11
At least for now, the selling continues. Rettig filed a flagging notification indicating their ownership has dropped below 15%, meaning around 350k shares were sold during October (sales in September were approximately 1.8 million shares). If Rettig’s sales continue, Coronaria will...
yesterday
by Nimimerkki
9
Here are Roni’s comments on this recent acquisition Terveystalo announced on Friday that it is acquiring Solo Health, a company focused on public sector healthcare services, which strengthens the company’s staffing services business and its position as a partner for wellbeing services...
9/7/2026, 5:18 AM
by Sijoittaja-alokas
9
Here are Roni’s brief comments on Terveystalo’s CFO leaving the company. Inderes – 17 Sep 26 Terveystalon talousjohtaja jättää yhtiön - Inderes Talousjohtajan lähtö kesken suurten yrityskauppojen on mielestämme ajoitukseltaan epäoptimaalinen.
9/17/2026, 5:07 AM
by Sijoittaja-alokas
7
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7.10
2026

Half year dividend

21.10
2026

Interim report Q3'26

Press release07.10.2026, 12.30

Terveystalo to host Q3/2026 results webcast and provide an update on the progress of its ARC strategy on 21 October 2026

Terveystalo
Regulatory press release06.10.2026, 12.30

Terveystalo Plc: Flagging announcement in accordance with Chapter 9, Section 10 of the Securities Markets Act

Terveystalo
Terveystalo, Webcast, Q3'26
Webcast21.10.2026, 09.30

Terveystalo, Webcast, Q3'26

Terveystalo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release02.10.2026, 08.00

Terveystalo Plc - Managers' transactions - Karotie

Terveystalo
Analyst Comment17.09.2026, 06.49 by
Roni Peuranheimo

Terveystalos finanssdirektør forlader selskabet

Efter vores opfattelse er timingen for finansdirektørens afgang midt i store virksomhedshandler suboptimale.

Terveystalo
Regulatory press release16.09.2026, 12.15

Composition of Terveystalo Plc's Shareholders' Nomination Board

Terveystalo
Regulatory press release16.09.2026, 08.00

Change in Terveystalo’s Executive Team: Juuso Pajunen to take up a new position outside the company

Terveystalo
Analyst Comment09.09.2026, 06.35

Børsurougen | Sundhed & Vækst og M&A 8.9.2026

Børsinvestorens ugentlige temaer Sundhed samt Vækst & M&A kan ses på inderesTV.

Aiforia TechnologiesTerveystaloOrionRelais GroupAspo
Terveystalo: Glans over estimaterne
Research08.09.2026, 07.00 by
Roni Peuranheimo

Terveystalo: Glans over estimaterne

Vi har opdateret vores estimater med opkøbet af Hohde Group, efter aftalen er blevet gennemført.

Terveystalo
Nyt endnu flere opkøb fra Terveystalo
Analyst Comment07.09.2026, 07.05 by
Roni Peuranheimo

Nyt endnu flere opkøb fra Terveystalo

Opkøbet af Solo Health giver et betydeligt vækstboost til vikarbranchen.

Terveystalo
Press release04.09.2026, 15.00

Terveystalo strengthens its ability to support wellbeing services counties through the acquisition of Solo Health

Terveystalo
Regulatory press release04.09.2026, 14.40

Ville Pesonen appointed SVP, Oral Health and member of Terveystalo’s Executive Team

Terveystalo
Regulatory press release04.09.2026, 14.35

Terveystalo to change its organisation and reporting structure in line with its updated strategy and operating model

Terveystalo
Regulatory press release04.09.2026, 14.30

Terveystalo completes the acquisition of Hohde Group

Terveystalo
Terveystalo har modtaget Konkurrence- og Forbrugermyndighedens godkendelse af Hohde-opkøbet mod lokale frasalg
Analyst Comment04.09.2026, 06.46 by
Roni Peuranheimo

Terveystalo har modtaget Konkurrence- og Forbrugermyndighedens godkendelse af Hohde-opkøbet mod lokale frasalg

Gennemførelsen af Hohde-handlen fordobler selskabets omsætning inden for mundsundhed.

Terveystalo
Regulatory press release03.09.2026, 11.25

Competition and Consumer Authority approves Terveystalo’s acquisition of Hohde Group subject to commitments

Terveystalo
Regulatory press release05.08.2026, 07.45

Sanna Ahonen appointed Terveystalo’s Chief Transformation Officer and member of Executive Team

Terveystalo
Terveystalo Q2'26: Indtjeningsvanskelighederne fortsætter
Research20.07.2026, 07.45 by
Roni Peuranheimo

Terveystalo Q2'26: Indtjeningsvanskelighederne fortsætter

Terveystalos Q2-regnskabsmeddelelse indeholdt ingen større overraskelser efter den negative nedjustering og de forudgående oplysninger, der blev givet før regnskabsmeddelelsen.

Terveystalo
Terveystalo, Webcast, Q2'26
Webcast17.07.2026, 09.30

Terveystalo, Webcast, Q2'26

Terveystalo
Regulatory press release17.07.2026, 08.00

Terveystalo Group Half-Year Report January–June 2026: Weak market conditions continued, actions taken to support profitability and growth

Terveystalo